Author:
Dietl B.,Sánchez I.,Arcenillas P.,Cuchi E.,Gómez L.,González de Molina F.J.,Boix-Palop L.,Nicolás J.,Calbo E.
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference19 articles.
1. Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI);Solomkin;Clin Infect Dis,2015
2. Ceftolozane–tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI);Wagenlehner;Lancet,2015
3. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant Gram-negative bacilli;Zhanel;Drugs,2014
4. Treatment of polymicrobial osteomyelitis with ceftolozane–tazobactam: case report and sensitivity testing of isolates;Jolliff;Case Rep Infect Dis,2016
5. Salvage therapy with ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections;Castón;Antimicrob Agents Chemother,2017
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献